Sena Dzakuma Hamidu , PhD c, MPH, PMP

-Led alliance strategy and execution for multi-billion-dollar global vaccine programs and managed partnerships with BARDA (~$1.6B), CEPI (~$400M), GAVI, and Serum Institute of India. -Drove business development efforts to originate and advance new customer opportunities, partnering cross-functionally to shape competitive proposals and grow pipeline revenue. -Designed and implemented governance frameworks, KPIs, and performance scorecards to monitor program health, manage risk, and ensure strategic alignment across global partners. -Served as the internal integration point across R&D, Regulatory, CMC, and Clinical teams enabling accelerated decision-making and accountability on complex, matrixed programs.

-Managed a $420M program portfolio in partnership with USAID, CDC, and the U.S. Department of State, overseeing health and development programs across 15+ countries in Latin America, Africa, the Middle East, and Asia-Pacific. -Spearheaded proposal development and bid defense for 20+ countries, securing competitive awards across pharmaceutical and medical program areas. -Defined and implemented KPIs, performance metrics, and process frameworks to increase award value, expand regional coverage, and ensure donor compliance. -Recruited, trained, and managed support staff, ensuring alignment with program delivery, reporting, and regulatory requirements. Built and sustained strong client relationships through proactive communication, high-quality delivery, and continuous integration of donor priorities into operational planning.

-Selected as a GSK Fellow to manage global drug donation programs funded by GSK and Johnson & Johnson targeting Neglected Tropical Diseases (NTDs) in partnership with the WHO. -Authored a peer-level epidemiological systematic review assessing the international NTD burden, informing strategy for GSK and global health partners. -Designed and implemented monitoring & evaluation (M&E) frameworks to measure treatment coverage, supply chain performance, and program impact in alignment with WHO targets. -Coordinated multi-stakeholder engagement across ministries of health, NGOs, and academic institutions to ensure timely delivery and uptake of donated pharmaceuticals in endemic regions.

-Advised on early-stage development and commercialization strategy for a novel rapid diagnostic platform differentiating malaria, bacterial, and viral causes of acute febrile illness in LMICs -Developed business and operating plan for a scalable manufacturing facility, including capital planning, workforce modeling, and go-to-market strategy -Conducted market, epidemiological, and health systems analyses to address misdiagnosis, treatment inefficiencies, and antimicrobial resistance -Aligned product strategy with Target Product Profile (TPP) informed by global health stakeholders (WHO, FIND, MSF Access Campaign, ReAct) -Partnered cross-functionally to advance a scalable, innovation-driven solution bridging early-stage development through commercialization across African markets

-Led health systems research initiatives focused on improving care delivery and population health outcomes within a public hospital network. -Analyzed clinical and operational data to identify gaps in access, utilization, and patient outcomes, translating findings into actionable recommendations for health system leadership. -Supported strategic planning efforts by integrating epidemiologic insights with policy and operational considerations to enhance healthcare delivery in underserved communities.